However, these parameters are significantly reduced in B-lymphocytes from FH (familial hypercholesterolemia) patients’ heterozygous for pathogenic variants in the LDLR gene (Figure 5A–C). This evidence concerns the gene LDLR and familial hypercholesterolemia.